Nasdaq Grants 180 Days To Agile Therapeutics To Regain Compliance With Listing Norms
Agile Therapeutics, Inc. (NASDAQ:AGRX) (“Agile” or the “Company”), awomen'shealthcarecompany,today announced that it has received written notification from the Listing Qualifications